about
Rituximab for eradicating inhibitors in people with acquired haemophilia AInterventions for treating acute bleeding episodes in people with acquired hemophilia AInterventions for treating acute bleeding episodes in people with acquired hemophiliaRituximab for eradicating inhibitors in people with acquired haemophilia ARituximab in the treatment of autoimmune haematological disorders.A case of severe unprovoked hemorrhage in an elderly male: a case report.Illustrated operative management of spontaneous bleeding and compartment syndrome of the lower extremity in a patient with acquired hemophilia A: a case report.The use of desmopressin in acquired haemophilia A: a systematic review.Acquired hemophilia: a case report and review of the literature.Identification of a shared F8 mutation in the Korean patients with acquired hemophilia AAcquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.The first case of postpartum acquired hemophilia A in Korea.Acquired hemophilia A presenting in an elderly manImmune tolerance therapy in patients with acquired hemophilia.Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.Duodenal tumor presenting as acquired hemophilia in an 88-year-old woman: a clinical case and review of the literature.Acquired coagulation inhibitor-associated bleeding disorders: an update.Management of bleeding emergencies: when to use recombinant activated factor VII.Rituximab in the treatment of acquired hemophilia.Acquired hemophilia A.Transient acquired hemophilia associated with Mycoplasma pneumoniae pneumoniaThe management of hemophilia in elderly patients.Acquired haemophilia A as a blood transfusion emergency.Acquired hemophilia A as a cause of acute upper gastrointestinal hemorrhageApproach to the treatment, characterization and diagnosis of an acquired auto-antibody directed against factors prothrombin, factor X and factor IX: a case report and review of the literature.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.How I manage patients with acquired haemophilia A.Unexpected hemorrhage: an unusual and potentially catastrophic clinical challenge.Perioperative management of acquired hemophilia a: a case report and review of literature.Defective α2 antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiency.Spontaneous multilevel airway haemorrhage in acquired haemophilia A.Acquired haemophilia secondary to ivabradine presenting with acute respiratory distress syndrome.Life-threatening hemorrhage from acquired hemophilia A as a presenting manifestation of prostate cancer.Successful treatment of acquired haemophilia with prednisolone therapy.Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine.Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases.Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions.Acquired factor VIII haemophilia in a patient with acute necrotic pancreatitis.
P2860
Q24186862-FB08130B-F0F2-4594-810E-26868291CB53Q24194263-71A65916-8CA6-4A8D-B987-C03BC2CFC3CCQ24197921-E6C295AD-8732-4C2E-92F8-E7117BC63F14Q26471152-9F915BCC-4B24-4362-86EA-43B0A7CB1261Q33378854-6B5F0FA9-C46C-435C-96BB-D7F7B71A1E01Q33863253-6464096E-BB07-4F46-A39C-F8D8E6D543CDQ33942704-AF028028-E06F-4AEF-BAEA-99B8B2F620A5Q34207741-80AB59F6-E271-4A64-998F-7165C3611C58Q34416230-92244585-57DB-48AF-9CB7-CD5611239E2EQ34729308-5D20BCF9-D011-45CF-AC98-36997A9CCCFBQ35096654-36D8583D-9404-452C-A88F-CC3034F31716Q35211987-36D806DC-39AE-47FC-B2D2-5DD49561A816Q35929394-92EDC253-DB8C-4D70-87B4-E0DA26E23C15Q35994817-E04CC4AD-CBDD-4DB2-96AE-102CE8A0918CQ36108261-CCFF7354-D845-486C-8857-209712975A75Q36187384-D1C88BA0-8DE9-4628-9CA8-7C06B66387A1Q36204461-68BA0C5C-3216-41DA-B413-9C946292E980Q36328387-63153531-A913-4F17-AC29-560BD705348FQ36349585-06BE4307-B03C-4087-87DB-F4B9C99574E7Q36492909-52EE42A4-F5FF-47E1-8F74-3CF8168412A3Q36497382-E94B5112-9F80-4CF5-9207-D0CD23CB80A1Q36854405-D711845E-97AD-42FA-83DB-8C77E9722874Q37017437-B6FE972E-68B8-4BAC-9B8F-5ED6B008C005Q37062411-5404B9A8-0214-49BC-B562-9085C4C3B0DEQ37570726-34F52F7E-9BE1-4184-B6E7-5ECB694364FCQ37894854-8BCE5021-7EFD-4587-82F6-95A83B0E4A56Q37944291-32204812-9B5D-4FDA-B84A-E5B146B694C7Q38000164-CA9F2145-67EF-4800-8DAF-8D9A5E45E3A5Q38078394-622E4910-328C-4228-990B-F58CB548730EQ38156405-F8BAA04B-88A1-4D04-9D84-840AC33A8291Q38198643-C71341DF-E2EA-4857-B4AF-7BD19D0416E5Q38779362-D11A0BFF-8E65-4195-9DA5-D6FF9D160810Q38941544-616E974E-4F63-4F68-AB45-5D7DF615B85AQ41899242-E3F52758-B01D-41D2-83AF-22411EE32F66Q42396736-B57FCF55-BC30-4B5D-BE39-F1922DD11EECQ44747824-C5AECFAA-62FA-4CC7-97C4-70F1A9FDFD05Q44987604-37746932-7A02-4841-A09A-8F86C7E28010Q45858971-01D52CDC-C663-4BCA-8809-D167F5FE9E13Q45859660-32F08152-C9E9-4F87-90CB-DFD0437A006EQ45864847-A5485A73-E7CA-43DB-9A53-A33D82F136F8
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Acquired hemophilia.
@ast
Acquired hemophilia.
@en
Acquired hemophilia.
@nl
type
label
Acquired hemophilia.
@ast
Acquired hemophilia.
@en
Acquired hemophilia.
@nl
prefLabel
Acquired hemophilia.
@ast
Acquired hemophilia.
@en
Acquired hemophilia.
@nl
P2860
P1476
Acquired hemophilia.
@en
P2093
P2860
P304
389-404; quiz following 431
P356
10.1046/J.1468-0734.2001.00049.X
P577
2001-12-01T00:00:00Z